Shore Capital Partners Sale of Home Infusion Therapy Portfolio Company

We represented Shore Capital Partners in the sale of its home infusion therapy portfolio company, SCP Specialty Infusion, to AxelaCare Health Solutions. Shore Capital Partners is a healthcare-focused, Chicago-based private equity firm. From 2009 to 2011 Shore Capital completed three add-on acquisitions, one of which was the acquisition of Sirona Infusion, LLC, to found SCP Specialty Infusion, and built three de novo pharmacies to become one of the largest privately-owned home infusion platforms.

Shore Capital Partners is a healthcare-focused, Chicago-based private equity firm.

You Also May Be Interested In:

  • Successfully represented AmSurg Holdings, Inc. in a dispute with a group of physicians seeking to invalidate a non-compete provision that was a material feature of a highly profitable surgery center partnership located in  Minnesota

    We represented AmSurg Holdings, Inc. in a dispute with a group of physicians seeking to invalidate a non-compete provision that...
    Client Type: Public Company
  • Representation of Triage Consulting Group, a healthcare revenue integrity company in its acquisition by Revint Solutions, a leader in technology-enabled revenue integrity solutions for healthcare providers

    We represented Triage Consulting Group, a healthcare revenue integrity company in its acquisition by Revint Solutions, a leader in technology-enabled...
    Client Type: Private Company
  • Representation of Twin River Worldwide Holdings, Inc. (NYSE: TRWH) in its definitive agreement to acquire Jumer’s Casino & Hotel, from Delaware North Companies Gaming & Entertainment, Inc., for $120 million in cash

     

    We represented Twin River Worldwide Holdings, Inc. in its definitive agreement to acquire Jumer's Casino & Hotel, from Delaware North...
    Client Type: Public Company